Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2024

Jun 14, 2024

62616_rns_2024-06-14_55739b54-c129-460d-8c16-525e2e5e6b98.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [144 x 47] intentionally omitted <==

June 14, 2024

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.

Scrip Code: 532531

Dear Sirs,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)

Reg: Completion of tenure of Mr. Bharat Dhirajlal Shah as Independent Director of the Company

We hereby inform you that Mr. Bharat Dhirajlal Shah has completed his second and final term as Independent Director of the Company with effect from closing business hours of June 14, 2024.

Mr. Shah is associated with Strides since July 2014. His rich experience in the financial services sector and expertise in the fields of banking, finance and securities market has immensely benefited the Company.

Board of Directors of the Company place on record their sincere appreciation for the valuable contributions made by Mr. Shah during his association with Strides.

Disclosure pursuant to Regulation 30 of SEBI Listing Regulations read with SEBI Circular of July 13, 2023 in relation to the above is enclosed as an Annexure.

This is for your kind information and record purpose.

Thanks & Regards,

For Strides Pharma Science Limited,

MANJULA Digitally signed by MANJULA R R Date: 2024.06.14 18:35:57 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

Encl. as above

==> picture [472 x 48] intentionally omitted <==

Annexure

==> picture [144 x 47] intentionally omitted <==

Disclosure pursuant to Regulation 30 of SEBI Listing Regulation read with SEBI Circular SEBI/ HO/ CFD/ CFD-PoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023

Completion of tenure of Mr. Bharat Dhirajlal Shah (DIN: 00136969) as Independent Director of the Company

# Details Information of such event
1. Reasons for change,~~viz., appointment,~~
~~resignation, removal, death~~or otherwise
Mr. Bharat Dhirajlal Shah (DIN: 00136969) has
completed his second and final term as Independent
Director of the Company with effect from closing
business hours of June 14, 2024.
2. Date of~~appointment/ re-appointment/~~
cessation~~and term of appointment/ re-~~
~~appointment~~
3. Brief profile (in case of appointment) Not Applicable
4. Disclosure of relationships between directors
(in case of appointment of a director)
5. Disclosure of relationship between directors
(in case of appointment of a director)

==> picture [472 x 48] intentionally omitted <==